YB-800ADC2

N/A

Report date: 2025/06/04 11:51:51

Base Information

Drug NameYB-800ADC2
Drug Alias NameYB-800ADC2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionNeuronal pentraxin receptor inhibitorsTubulin inhibitorsDNA topoisomerase inhibitors
TargetsNeuronal pentraxin receptorTubulinDNA topoisomerase
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesYmmunobio AG
China Registration ClassN/A

Develop Information

Active CompaniesYmmunobio AG
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A